70 related articles for article (PubMed ID: 4795333)
1. [Clinical examination of proteolytic enzyme preparation, seaprose S, in liquefaction of the sputum: comparison using a double blind test].
Ito F; Uchida H; Konishiike J; Yamazaki M; Yamamoto Y
Nihon Rinsho; 1973 Jul; 31(7):2339-44. PubMed ID: 4795333
[No Abstract] [Full Text] [Related]
2. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
[TBL] [Abstract][Full Text] [Related]
3. A new method for evaluating mucolytic expectorant activity and its application. II. Application to two proteolytic enzymes, serratiopeptidase and seaprose.
Kasé Y; Seo H; Oyama Y; Sakata M; Tomoda K; Takahama K; Hitoshi T; Okano Y; Miyata T
Arzneimittelforschung; 1982; 32(4):374-8. PubMed ID: 7049188
[TBL] [Abstract][Full Text] [Related]
4. Effects of seaprose on sputum biochemical components in chronic bronchitic patients: a double-blind study vs placebo.
Moretti M; Bertoli E; Bulgarelli S; Testoni C; Guffanti EE; Marchioni CF; Braga PC
Int J Clin Pharmacol Res; 1993; 13(5):275-80. PubMed ID: 8200722
[TBL] [Abstract][Full Text] [Related]
5. [Effects of various expectorants on sputum viscoelasticity in vivo (author's transl)].
Shimura S; Sato S; Aoki T; Takishima T
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Mar; 18(3):161-70. PubMed ID: 7392320
[No Abstract] [Full Text] [Related]
6. Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
Braga PC; Bossi R; Allegra L
Drugs Exp Clin Res; 1987; 13(11):707-10. PubMed ID: 3443046
[TBL] [Abstract][Full Text] [Related]
7. The mucolytic agent bromhexine (bisolvon) in chronic lung disease. A double-blind crossover trial.
Cobbin DM; Elliott FM; Rebuck AS
Aust N Z J Med; 1971 May; 1(2):137-40. PubMed ID: 4935896
[No Abstract] [Full Text] [Related]
8. In vitro rheological assessment of mucolytic activity induced by seaprose.
Braga PC; Rampoldi C; Ornaghi A; Caminiti G; Beghi G; Allegra L
Pharmacol Res; 1990; 22(5):611-7. PubMed ID: 2277801
[TBL] [Abstract][Full Text] [Related]
9. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo.
Shimura S; Okubo T; Maeda S; Aoki T; Tomioka M; Shindo Y; Takishima T; Umeya K
Biorheology; 1983; 20(5):677-83. PubMed ID: 6375756
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of the simultaneous aerosol administration of fenoterol and 2(alpha-thenoylthio)propionylglycine].
Ardizzi A; Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1823-6. PubMed ID: 3534632
[TBL] [Abstract][Full Text] [Related]
11. The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections.
Braga PC; Piatti G; Grasselli G; Casali W; Beghi G; Allegra L
Drugs Exp Clin Res; 1992; 18(3):105-11. PubMed ID: 1425205
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.
Gallon AM
Thorax; 1996 Apr; 51(4):429-32. PubMed ID: 8733499
[TBL] [Abstract][Full Text] [Related]
13. [Comparative investigation on sputum viscosity before and after administration of mistabron or physiological saline solution with and without physiotherapy (vibration-therapy) (author's transl)].
Maesen F; Brombacher PJ; Buytendijk HJ; Janssen HC
Acta Tuberc Pneumol Belg; 1974; 65(2):212-8. PubMed ID: 4371451
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
Aylward M; Maddock J; Dewland P
Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835
[No Abstract] [Full Text] [Related]
15. Mucolytic effects of domiodol in tracheostomized patients after total laryngectomy. Double-blind, placebo-controlled, randomized pilot study with four-month follow-up.
Antonelli A; Carraro A; Donati C; Garrubba V
Arzneimittelforschung; 1992 Feb; 42(2):126-32. PubMed ID: 1610421
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of the efficacy of and tolerance to seaprose S in inflammatory venous disease. Controlled study versus serratio-peptidase].
Bracale G; Selvetella L
Minerva Cardioangiol; 1996 Oct; 44(10):515-24. PubMed ID: 9091835
[TBL] [Abstract][Full Text] [Related]
17. [Proteolytic and antiproteolytic potential of the sputum in chronic bronchitis patients during exacerbation].
Khomenko AG; Kaminskaia GO; Pylluste IaA; Zhukova NL; Ozerova LV
Ter Arkh; 1983; 55(3):60-3. PubMed ID: 6344303
[No Abstract] [Full Text] [Related]
18. [Sputum mucopolysaccharides].
Bürgi H
Ther Umsch; 1965 Jul; 22(7):331-2. PubMed ID: 4220830
[No Abstract] [Full Text] [Related]
19. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
20. Effects of Varidase buccal tablets on the sputum.
Nagaoka S; Yamanaka E; Nakazawa Y; Katano F
Clin Ther; 1980; 3(2):137-42. PubMed ID: 7448844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
